As of 2024-09-19, the Intrinsic Value of Radius Health Inc (RDUS) is
70.75 USD. This RDUS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 17.14 USD, the upside of Radius Health Inc is
312.80%.
The range of the Intrinsic Value is 49.61 - 115.55 USD
70.75 USD
Intrinsic Value
RDUS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
49.61 - 115.55 |
70.75 |
312.8% |
| DCF (Growth 10y) |
68.91 - 146.95 |
94.12 |
449.1% |
| DCF (EBITDA 5y) |
106.51 - 150.55 |
118.57 |
591.7% |
| DCF (EBITDA 10y) |
119.60 - 177.93 |
137.78 |
703.9% |
| Fair Value |
-246.20 - -246.20 |
-246.20 |
-1,536.38% |
| P/E |
(563.30) - 19.55 |
(277.97) |
-1721.8% |
| EV/EBITDA |
9.76 - 127.35 |
65.29 |
280.9% |
| EPV |
18.11 - 28.45 |
23.28 |
35.8% |
| DDM - Stable |
(71.47) - (178.44) |
(124.96) |
-829.0% |
| DDM - Multi |
38.68 - 75.88 |
51.33 |
199.5% |
RDUS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
480.61 |
| Beta |
0.79 |
| Outstanding shares (mil) |
28.04 |
| Enterprise Value (mil) |
866.66 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.31% |
| Cost of Debt |
6.10% |
| WACC |
7.81% |